572 related articles for article (PubMed ID: 36047183)
21. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
22. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
23. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
[TBL] [Abstract][Full Text] [Related]
25. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
[TBL] [Abstract][Full Text] [Related]
26. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
[TBL] [Abstract][Full Text] [Related]
27. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.
Mekonnen ZK; Ashraf DC; Jankowski T; Grob SR; Vagefi MR; Kersten RC; Simko JP; Winn BJ
Ophthalmic Plast Reconstr Surg; 2021 Mar-Apr 01; 37(2):e40-e80. PubMed ID: 33229953
[TBL] [Abstract][Full Text] [Related]
28. COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.
Walia S; Bhaisare V; Rawat P; Kori N; Sharma M; Gupta N; Urdhwareshwar S; Thakur S; Arya N
Indian J Ophthalmol; 2021 Dec; 69(12):3685-3689. PubMed ID: 34827023
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
30. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.
Chiurlo M; Mastrangelo A; Ripa M; Scarpellini P
New Microbiol; 2021 Apr; 44(2):71-83. PubMed ID: 34240742
[TBL] [Abstract][Full Text] [Related]
32. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
Chouhan M; Solanki B; Shakrawal N
J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
[TBL] [Abstract][Full Text] [Related]
33. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
34. Histopathological Study of Mucormycosis in Post COVID-19 Patients and Factors Affecting it in a Tertiary Care Hospital.
Sree Lakshmi I; Kumari BS; Jyothi C; Devojee M; Padma Malini K; Sunethri P; Bheemrao Somalwar S; Kavitha T
Int J Surg Pathol; 2023 Feb; 31(1):56-63. PubMed ID: 35668640
[No Abstract] [Full Text] [Related]
35. Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids.
Tabarsi P; Khalili N; Pourabdollah M; Sharifynia S; Safavi Naeini A; Ghorbani J; Mohamadnia A; Abtahian Z; Askari E
Am J Trop Med Hyg; 2021 Jul; 105(2):449-453. PubMed ID: 34237015
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
38. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
39. Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
Seidel D; Simon M; Sprute R; Lubnow M; Evert K; Speer C; Seeßle J; Khatamzas E; Merle U; Behrens C; Blau IW; Enghard P; Haas CS; Steinmann J; Kurzai O; Cornely OA
Mycoses; 2022 Jan; 65(1):103-109. PubMed ID: 34655486
[TBL] [Abstract][Full Text] [Related]
40. Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.
Dhakal A; Pokharel M; Madhup S; Khadka L; Sapkota B
Kathmandu Univ Med J (KUMJ); 2022; 20(78):249-251. PubMed ID: 37017177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
